Table 2 Baseline characteristics showed there was no statistical difference in the training group and test group.

From: Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy

Variables

Training group (n = 241)

Validation group (n = 103)

p Value

Age (years)

40 (29, 54)

48 (31, 55)

0.112

Gender, n (male, %)

131 (54.3)

63 (61.1)

0.244

SBP (mmHg)

130 (119, 139)

128 (120, 139)

0.745

DBP (mmHg)

81 (77, 90)

80 (76, 86)

0.278

RBC (1012/L)

4.47 ± 0.63

4.52 ± 0.61

0.706

WBC (109/L)

6.50 (5.30, 7.90)

6.1 (5.2, 7.6)

0.268

PLT (109/L)

234 (197, 279)

236 (186, 286)

0.694

Eos (109/L)

0.14 (0.08, 0.24)

0.10 (0.06, 0.16)

0.002

Eos%

2.20 (1.40, 3.40)

1.90 (1.05, 2.70)

0.009

Hb (g/L)

134.4 ± 20.6

133.3 ± 19.3

0.648

MCH (pg)

30.4 (29.3, 31.5)

30.2 (29.0, 31.4)

0.863

MCHC (g/L)

333 (327, 340)

333 (327, 337)

0.459

TP (g/L)

46.6 (40.6, 54.4)

45.8 (39.7, 53.0)

0.648

ALB (g/L)

24.0 (19.5, 30.8)

22.9 (18.5, 31.0)

0.439

TCHO (mmol/L)

7.79 (5.70, 10.29)

6.90 (5.09, 9.64)

0.095

TG (mmol/L)

2.08 (1.36, 2.94)

1.85 (1.42, 2.50)

0.219

LDL (mmol/L)

5.14 (3.65, 7.88)

4.89 (3.31, 8.19)

0.472

HDL (mmol/L)

1.41 (1.12, 1.79)

1.32 (1.09, 1.78)

0.490

eGFR (ml/min/1.73 m2)

105.36 (88.83, 117.63)

98.96 (80.73, 110.67)

0.057

Scr (μmol/L)

69.0 (58.5, 84.5)

73.0 (60.0, 90.9)

0.141

Urea (mmol/L)

4.90 (3.80, 6.75)

5.00 (4.00, 6.60)

0.696

UA (μmol/L)

309 (254, 377)

324.0 (273, 395)

0.094

CRP (mg/L)

0.70 (0.00, 2.00)

1.00 (0.17, 2.04)

0.322

ESR (mm/h)

37.0 (20.0, 68.0)

44.0 (21.5, 68.0)

0.418

C3 (g/L)

1.37 (1.20, 1.56)

1.32 (1.13, 1.52)

0.159

C4 (g/L)

0.31 (0.25, 0.37)

0.32 (0.28, 0.37)

0.097

24hTP (g)

5.05 (2.38, 8.58)

5.16 (2.55, 7.81)

0.971

Urine volume (L)

1.5 (1.0, 2.1)

1.5 (1.0, 2.2)

0.787

Thrombosis, n (%)

4 (1.66)

2 (1.94)

1.000